Appriss® Inc., a leading technology provider for risk assessment and analytics, announced it has acquired NARXCHECK™ from the National Association Boards of Pharmacy Foundation™ (NABPF™).
- Government & Insurers
Large entities with substantial prescription databases to manage and evaluate will benefit from our Insight product.
- Hospitals & Pharmacies
NARXCHECK Plus is a fully automated program for locations that see a high volume of patients and need real-time data quickly recovered.
- Private Practices
NARxCHECK Direct provides a patient’s NARxCHECK Scores and NARxCHECK Report along with other patient data via a single sign-on in the provider’s electronic medical record system.
The full, provider-focused version of our software is powered by an ADT feed and automatically delivers PMP reports and NARxCHECK Scores for narcotics, plus sedatives and stimulants. An additional layer of intuitive patient management tools allow for enhanced care coordination.Read More
Surveilling a large database of prescription data is an important task for many organizations. Effective identification of abuse, outlier prescribing practices, and improper dispensing patterns can have profound effects on patient safety and cost. Our Insight product (in development) provides unparalleled awareness to those charged with finding disparites.Read More
|Product Statistics - Reports Delivered|
|7,027,598 In total||389,746 30 day avg.||12,992 24 hr avg.||541 1 hour avg.|
NARxCHECK on the Web
People who frequently abuse opiate painkillers are often at the highest risk of overdosing, and are also likely to obtain the drugs through multiple prescriptions and multiple doctors, a practice known as “doctor shopping,” reports a Centers for Disease Control and Prevention study.
Appriss Inc. appreciates the National Association of Boards of Pharmacy’s (NABP) support of its efforts to help practitioners identify and reduce the incidences of substance abuse through the use of the NARxCHECK tool. Appriss operates the NARxCHECK program with the mission of keeping communities safe and informed as part of its efforts to help practitioners utilize prescription monitoring program data more effectively. With this tool, practitioners can make more informed decisions when abuse is suspected and ensure that those who legitimately need controlled substances can receive them.